By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company XTL Biopharmaceuticals Ltd.

XTL Biopharmaceuticals Ltd. (XTLB)

NASDAQ Currency in USD
$1.40
+$0.08
+5.68%
Last Update: 11 Sept 2025, 20:00
$7.60M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.86 - $2.63
52 Week Range

XTLB Stock Price Chart

Explore XTL Biopharmaceuticals Ltd. interactive price chart. Choose custom timeframes to analyze XTLB price movements and trends.

XTLB Company Profile

Discover essential business fundamentals and corporate details for XTL Biopharmaceuticals Ltd. (XTLB) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

1 Sept 2005

Employees

10.00

CEO

Noam Band

Description

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company's lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel.

XTLB Financial Timeline

Browse a chronological timeline of XTL Biopharmaceuticals Ltd. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 1 Jan 2025

EPS came in at -$0.04 .

Earnings released on 30 Dec 2024

EPS came in at -$0.13 , while revenue for the quarter reached $162.00K .

Earnings released on 26 Sept 2024

EPS came in at -$0.07 .

Earnings released on 13 May 2024

EPS came in at $0.10 .

Earnings released on 27 Mar 2024

EPS came in at -$0.14 .

Earnings released on 15 Nov 2023

EPS came in at -$0.04 .

Earnings released on 10 Aug 2023

EPS came in at -$0.07 .

Earnings released on 16 May 2023

EPS came in at -$0.17 .

Earnings released on 22 Mar 2023

EPS came in at -$0.14 .

Earnings released on 29 Nov 2022

EPS came in at -$0.15 .

Earnings released on 24 Aug 2022

EPS came in at -$0.10 .

Earnings released on 1 Jun 2022

EPS came in at $0.00 .

Earnings released on 30 Mar 2022

EPS came in at $0.40 .

Earnings released on 24 Nov 2021

EPS came in at -$0.00 .

Earnings released on 24 Aug 2021

EPS came in at -$0.22 .

Earnings released on 19 May 2021

EPS came in at $0.05 .

Earnings released on 15 Mar 2021

EPS came in at $0.04 .

Earnings released on 31 Dec 2020

EPS came in at $0.00 .

XTLB Stock Performance

Access detailed XTLB performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run